German biomedical engineering at its best!

The number of Americans with Actinic Keratosis (AK), a potential precancer of the skin, is currently estimated to be 58 Million.1

 

Americans suffer from Actinic Keratoses

 

Red Light Photodynamic Therapy (PDT) with Nanoemulsion Technology

PDT is a very effective treatment for AK. Now, you have a new option to consider when looking for an AK therapy that is right for you.

Ameluz® (aminolevulinic acid hydrochlo­ride) gel, 10%, is an FDA approved prescription drug with a unique nanoemulsion formulation. It is indicated for the treatment of mild and moderate actinic keratoses on the face and scalp in combination with the BF-RhodoLED® lamp.2

Read More

BF-RhodoLED® is a red light emitting LED lamp, approved for the use in photodynamic therapy (PDT) with Ameluz®. Red light PDT is a non-invasive, irradiation free treatment for Actinic Keratoses (AK), a skin condition that can potentially develop into non-melanoma skin cancer.2

Read More

Biofrontera is a German pharmaceutical company, established in 1997, specializing in drugs and medical cosmetics for the care of your skin. Ameluz® and the BF-RhodoLED® lamp have been developed in-house by Biofrontera and obtained approval in the US and in Europe.

Read More
1 Skin Cancer Foundation 2 Ameluz® Prescribing Information. For Ameluz® full Prescribing Information and BF-RhodoLED® user manual please visit www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=650daa9f-aeec-49ce-95b9-5fa20b988afd